Ehlers-Danlos syndrome, fibronectinemic type

Ehlers-Danlos syndromes (EDS) form a heterogeneous group of inherited connective tissue disorders characterized by variable joint hypermobility and cutaneous hyperextensibility. Type X is distinguished by platelet dysfunction associated with a fibronectin abnormality. Type X EDS has been described in only one family so far. Age of onset is about 13-25 years. Transmission is autosomal recessive.

Also known as: EDS X, Ehlers-Danlos syndrome type 10, Ehlers-Danlos syndrome with platelet dysfunction from fibronectin abnormality, Ehlers-Danlos syndrome, fibronectin-deficient, EDS 10, EDS10 (formerly), Ehlers-Danlos syndrome type 10 (formerly), Ehlers-Danlos syndrome, dysfibronectinemic type

51 clinical trials for this condition and its sub-types.